VCRE
Vicore Pharma Holding AB
VCRE
Closed
$12.50
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.
Key stats
Open
$12.01
Volume
4.73K
Market cap
$329.39M
Prev. close
$12.50
Impl / hst vl
-
Open interest
$0.00
$11.48
Day’s Range
$12.50
$10.50
52W Range
$17.80
Valuation
33
Valuation score
Overvalued
P/E
-
P/S
980.63
P/B
3.49
Current ratio
12.69
Debt / Equity
-0.38
ROE
-50.04%
Gross margin
-
Income growth
-20.78%
FCF growth
42.11
Analysts estimates
Consensus rating
Buy
The average rating from top 7 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$28.37
The top 8 analysts forecasts that 12-month price may increase by 126.99%, with a low of $15.90 and a high of $41.88
$15.90
Low
$28.37
Avg
$41.88
High
Current price
Earnings
Q1 ‘26 revenue
$63.57K
Q1 ‘26 net income
-$11.47M
Revenue
Net income
Previous EPS
-$0.04
Estimate EPS
-$0.05
Actual EPS
Estimate EPS
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply